Your browser doesn't support javascript.
loading
Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial.
Ascierto, Paolo A; Dummer, Reinhard; Gogas, Helen J; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem B; Yamazaki, Naoya; Loquai, Carmen; Robert, Caroline; Flaherty, Keith T.
Afiliação
  • Ascierto PA; Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
  • Dummer R; Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland.
  • Gogas HJ; Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece.
  • Arance A; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Mandala M; Santa Maria Misericordia Hospital, University of Perugia, Perugia, Italy.
  • Liszkay G; Department of Dermatology, National Institute of Oncology, Budapest, Hungary.
  • Garbe C; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany.
  • Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, Germany.
  • Krajsova I; German Cancer Consortium, Partner Site Essen, Essen, Germany.
  • Gutzmer R; Department of Dermatology and Venereology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Chiarion-Sileni V; 1Department of Dermatology, Skin Cancer Center Minden, Mühlenkreiskliniken, Ruhr University Bochum, Minden, Germany.
  • Dutriaux C; 2Melanoma Cancer Unit, Istituto Oncologico Veneto IRCCS, Padua, Italy.
  • de Groot JWB; 3Department of Oncologic Dermatology, Bordeaux University Hospital Center, Bordeaux Cédex, France.
  • Yamazaki N; 4Isala Oncology Center, Isala, Zwolle, the Netherlands.
  • Loquai C; 5Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Robert C; 6Department of Dermatology, Klinikum Bremen-Ost, Gesundheitnord gGmbH, Bremen, Germany.
  • Flaherty KT; 7Department of Medicine, Service of Dermatology, Paris-Saclay University, Cedex, France.
J Clin Oncol ; 41(29): 4621-4631, 2023 10 10.
Article em En | MEDLINE | ID: mdl-37506329
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article